硫酸氢氯吡格雷片处方和制备工艺研究

高原 蔡轶军 高峰

中国药学杂志 ›› 2011, Vol. 46 ›› Issue (2) : 117-123.

PDF(1667 KB)
PDF(1667 KB)
中国药学杂志 ›› 2011, Vol. 46 ›› Issue (2) : 117-123.
论著

硫酸氢氯吡格雷片处方和制备工艺研究

  • 高原1,蔡轶军2,高峰1*
作者信息 +

Investigation of Formulation and in-Process Parameters of Clopidogrel Bisulfate Tablets

  • GAO Yuan1, CAI Yi-jun2, GAO Feng 1*
Author information +
文章历史 +

摘要

目的 制备稳定的硫酸氢氯吡格雷片(CPG, Ⅰ型,并考察影响颗粒特性的关键处方和工艺参数,以解决压片时的黏片现象,并确保稳定性。方法 研究原料辅料的相容性并筛选处方,考察直接压片、滚压法和熔融法对杂质、压片特性和溶出度的影响。结果 影响CPG稳定性最显著的因素是水分,其次为光照和温度;与滚压法、直接压片相比,熔融制粒的工艺更优;硬脂富马酸钠可防止压片时的黏片现象;溶出度与进口“波立维”相似因子f2>50;3个月加速实验结果表明,稳定性良好。结论 制备工艺重现性良好,片剂质量稳定。

Abstract

OBJECTIVE To investigate the formulation and process for preparing stable clopidogrel bisulfate tablets (Form I by elucidating the critical formulation and in-process parameters affecting critical granule properties, in order to solve sticking problems in tablet processing as well as improving stability under storage. METHODS Drug-excipient interactions were evaluated, and different dry granulations such as direct compression, melt granulation and roller compaction were compared, in terms of impurity levels, tablet properties and in vitro dissolution. RESULTS The stability of free clopidogrel bisulfate was liable to the high moisture, strong light and elevated temperature. Compared with direct compression and roller compaction, melt granulation was more suitable to prepare clopidogrel bisulfate tablet. Sodium stearyl fumarate avoided sticking problem in tablet processing with PEG 6000. Comparable dissolution profiles were obtained and similar to that of Pavix of Sinofi, with the similar factors above 50. Furthermore, the accelerated stability test suggested that tablets prepared by melt granulation under storage at 40 C and 75% RH for 3 months were stable and showed good physicochemical properties. CONCLUSION The CPG tablets were stable and the established processes were simple and reproducible.

关键词

硫酸氢氯吡格雷 / 熔融制粒 / PEG6000 / 相容性 / 稳定性 / 体外溶出

Key words

clopidogrel bisulfate / melt granulation / PEG 6000 / compatibility / stability / in vitro dissolution

引用本文

导出引用
高原 蔡轶军 高峰. 硫酸氢氯吡格雷片处方和制备工艺研究[J]. 中国药学杂志, 2011, 46(2): 117-123
GO Yun;CI Yi-jun;GO Feng . Investigation of Formulation and in-Process Parameters of Clopidogrel Bisulfate Tablets[J]. Chinese Pharmaceutical Journal, 2011, 46(2): 117-123

参考文献


[1] NI H C,FAN W H. Clopidogrel-a new autiplatelet [J].Chin J New Drugs(中国新药杂志,2001,10(12:888-891.
[2] BOUSQUET A, CASTTO B, SAINT-GERMAIN J. Polymorphic clopidogrel hydrogenesulphate form. US, 6429210.[P]. 2002-08-06.
[3] MOHAN A, HARIHARAN M, VIKRAMAN E, et al. Identification and characterization of a principal oxidation impurity in clopidogrel drug substance and drug product[J].J Pharm Biomed Anal, 2008,47(1:183-189.
[4] GOMEZ Y, ADAMS E, HOOGMARTENTS J. (2004 Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand[J]. J Pharm Biomed Anal, 2004,34(2: 341-348.
[5] USP. 30 NF25[S]. 2006:1803-1804.
[6] HEGDE D A, CHOTHE S S, CHONGARI I S, et al. Novel stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof. WO, 2008122994[P].2008-10-16.
[7] SHERMAN B C. Clopidogrel bisulfate tablet formulation. US, 6914141[P].2005-01-05.
[8] GAO Y,WANG H G,ZHANG R H,et al. Melt granulation in high shear mixer: research progress[J]. Chin Pharm J(中国药学杂志, 1999, 34(3:149-152.
PDF(1667 KB)

Accesses

Citation

Detail

段落导航
相关文章

/